NICOLE MADDOX: Open Payments
NPI 1093276156 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 20 payments from 11 companies in 2025. Trend: 2023 $520 · 2024 $578 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $80 |
| Incyte Corporation | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $35 |
| BIOPROTECT MEDICAL, INC. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Stemline Therapeutics Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
Products named: JEMPERLI, JAKAFI, BIOPROTECT BALLOON IMPLANT SYSTEM, NINLARO, Orserdu, FRUZAQLA, PLUVICTO, EPKINLY.
Industry payments across AL — which companies pay providers there.
